TY - JOUR AU - Doran, M. F. AU - Crowson, C. S. AU - Pond, G. R. AU - O’Fallon, W. M. AU - Gabriel, S. E. PY - 2002 DA - 2002// TI - Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study JO - Arthritis Rheum VL - 46 UR - https://doi.org/10.1002/art.10524 DO - 10.1002/art.10524 ID - Doran2002 ER - TY - JOUR AU - Gelinck, L. B. AU - Bijl, A. E. AU - Visser, L. G. AU - Huizinga, T. W. AU - Hogezand, R. A. AU - Rijkers, G. T. PY - 2008 DA - 2008// TI - Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody responses to the 23 valent pneumococcal polysaccharide vaccine JO - Vaccine VL - 26 UR - https://doi.org/10.1016/j.vaccine.2008.04.028 DO - 10.1016/j.vaccine.2008.04.028 ID - Gelinck2008 ER - TY - JOUR AU - Manetta, J. AU - Bina, H. AU - Ryan, P. AU - Fox, N. AU - Witcher, D. R. AU - Kikly, K. PY - 2014 DA - 2014// TI - Generation and characterization of tabalumab, a human monoclonal antibody that neutralizes both soluble and membrane-bound B-cell activating factor JO - J Inflamm Res VL - 7 ID - Manetta2014 ER - TY - JOUR AU - Smolen, J. S. AU - Weinblatt, M. E. AU - Heijde, D. AU - Rigby, W. F. AU - Vollenhoven, R. AU - Bingham, C. O. PY - 2015 DA - 2015// TI - Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study JO - Ann Rheum Dis VL - 74 UR - https://doi.org/10.1136/annrheumdis-2014-207090 DO - 10.1136/annrheumdis-2014-207090 ID - Smolen2015 ER -